Martek Biosciences Corporation is engaged in the innovation and development of nutritional products from microbial sources, including algae, fungi and other microbes, that promote health and wellness. The Company's innovation and development is based on its technology in areas, such as microbial biology, algal genomics, fermentation and oil processing.
The Company developed and commercialized life'sDHA, a vegetarian source of the omega-3 fatty acid docosahexaenoic acid (DHA), for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feed.
Martek also produces life'sARA, a vegetarian source of the omega-6 fatty acid arachidonic acid (ARA), for use in infant formula. Its wholly-owned subsidiaries include Martek Biosciences Boulder Corporation and Martek Biosciences Kingstree Corporation.
February 2010, the Company completed the acquisition of Amerifit Brands, Inc. from Charterhouse Group, Inc.
Dec 2010 - Royal DSM N.V. and Martek Biosciences Corporation announce that they have entered into a definitive agreement under which DSM will acquire all the outstanding shares of common stock of Martek
Southwest Atlantic Squid Index: Illex Squid (Illex Argentinus) China
In order to continuously enhance the ability to control squid resources and price influence, and conduct more accurate resource assessment and forecasting, the China Ocean Fisheries Association&n...
Fishing Exports Increased by 10.4% in Q1 Argentina
This increase can be largely explained by the significant increase in squid sales compared to the same period last year, something that could change starting in April due to high competition from the ...